Showing posts with label Bioengineering. Show all posts
Showing posts with label Bioengineering. Show all posts

Friday, August 15, 2025

bioengineered naringenin molecule fights inflammation

UA Scientists Create Bioengineered Naringenin Molecule to Combat Inflammation and Boost Healing

Illustrative diagram showing NAR conjugation alongside nanoparticle analysis. Credit: Science Advances (2025). DOI: 10.1126/sciadv.adw1358.

Introduction

Researchers from the University of Alabama have devised a bioengineered molecule harnessing a natural compound to address and alleviate inflammation.

Naringenin: Natural Anti-Inflammatory and Absorption Challenges

Naringenin, a flavonoid occurring naturally in citrus fruits, is well known for its anti-inflammatory and antioxidant effects. Yet, the human body struggles to absorb it effectively from good or existing supplements. Typically, it begins to degrade in the stomach's acidic environment and what remains finds it difficult to pass through the intestinal wall into the blood. The University of Alabama researchers have now managed to harness its inflammation-combating potential.

Patented Drug Delivery Technique

Published in Science Advances, the research employs a patented technique devised by UA's Drug Research and Engineering for Advanced Medicine Laboratory.

Biodegradable Polymer Casing

This involves enclosing the drug within a biodegradable polymer casing, the surface of which is adorned with extra naringenin molecules acting as ligands, enabling them to bind with specialized receptors present on cell surfaces in the gut.

Ligand-Receptors Binding Discovery

Researchers at UA discovered that naringenin binds effectively as a ligand to a specific receptor type. These receptors act as entry points, permitting the medicine to pass through rather than excluding it.

"This marks the first occasion that a single molecule has been employed for both guidance and healing," explained Dr. Meenakshi Arora, associate professor at UA and principal investigator of the project. "Our dual-function nanoparticles enhance drug delivery while also reinstating immune balance and limiting tissue damage."

Significant Improvements Seen in Kidney Damage Trials

In a mouse model of acute kidney injury triggered by cisplatin, a widely used chemotherapy agent, the research team showed that their dual-action nanoparticles could:

  • Lessen kidney damage and inflammation.
  • Reduce key inflammatory markers.
  • Restore immune cell performance and counter immune exhaustion.
  • Deliver therapeutic results at only half the dosage of standard treatments.

The findings indicate that the therapy not only combats inflammation but also encourages the repair of both kidney and liver tissue. For those undergoing cancer treatment, this may translate to reduced side effects and shorter recovery periods, aided by a supplement suitable for home use.

Regulatory Advantages and Broader Potential

Nearly every element of the dual-function naringenin particle is already approved for human use, simplifying the route through regulatory procedures. Researchers are now exploring its potential in treating other health issues, including cancer.

Adaptability of the System

"One of the advantage of this system is its remarkable adaptability," explained Assistant Professor Dr. Raghu Ganugula, the team's molecular pharmacologist. "It can be fine-tuned according to drug concentrations and ligand-receptor dynamics."

The results of the study could influence treatments for numerous inflammatory conditions, such as autoimmune disorders, sepsis, arthritis and liver disease.

Arora explained, "In the end, our findings demonstrate a robust proof-of-concept for a new generation of oral drug delivery platforms, which may offer more effective treatment at lower doses for inflammatory conditions."

The Importance of Dosage

The animal model component of the study was managed by third-year PhD student Abiodun Wahab, whose veterinary background equipped her with the knowledge and determination to pursue safer dosing methods.

Veterinary Insights into Dosage Risks

"As an undergraduate during may placement at a veterinary clinic, I often treated animals suffering from parasitic infections," he said.

The drug commonly prescribed for treating parasites proved highly effective, though it carried risks if administered in the wrong dose.

"So I arrived with the understanding that one must be cautious about both the dosage and how often it is administered," Wahab remarked. "Discovering this innovative system for lowering drug concentrations and associated toxicities was particularly significant for me."

Source

Breakthrough like this bioengineered naringenin therapy show how science can reshape healthcare by making treatments more effective and safer.

Human Health Issues - Stay informed with expert insights, research updates and tips for maintaining a healthier life.

FSNews365 - Your trusted hub for the latest innovations in science, technology, space and groundbreaking research from around the world.

Earth Day Harsh Reality - Discover urgent environmental issues and actions we can take to protect our planet's future.

Friday, July 4, 2025

brain organoid platform mild blast TBI research

Brain Organoid Platform Aims to Decode Mild Blast Traumatic Brain Injury in Military personnel

Traumatic Brain Injury: A Persistent Challenge for Military personnel

Traumatic brain injuries have remained a persistent issue among military personnel, with the Department of Defence reporting close to 516.000 cases globally between 2000 and 2024.

Johns Hopkins Launches POSITRONIC to Study mbTBI

A research team from Johns Hopkins Applied Physics Laboratory (APL) in Laurel, Maryland, together with the Johns Hopkins Bloomberg School of Public Health, is developing a next-generation brain-organoid platform to tackle this challenge. Their studyPlatform to Optimally Study Injury and TRauma On Neural Integrity and Circuitry (POSITRONIC), published in Frontiers in Bioengineering and Biotechnologyoutlines the core principles of platforms designed for investigating low-level blast exposure.

Understanding Low-Level Blast Exposure

"The cumulative impact of low-level blast exposure remains poorly understood, largely due to our limited capacity to detect subtle effects on the human body—effects that may appear immediately but unfold gradually over time," said Katy Carneal, Assistant Programme Manager for Biological and Chemical Sciences at APL.

The Hidden Risk of Repeated Exposure

Low-level blasts produce pressure waves that travel through the skull and interact with brain tissue: repeated exposure can result in mild blast-induced traumatic brain injury (mbTBI). Military and low enforcement personnel may be exposed to over 100 such blasts during certain training exercises—and considerably more over the course of their careers.

Developing the POSITRONIC Prototype Platform

"Our aim is to create a prototype platform that will enable a deeper understanding of mbTBI caused by repeated low-level blasts, using advances in brain organoid technology and non-invasive optical imaging," said Eyal Bar-Kochba, Chief Scientist at APL's Research and Exploratory Development Department (REDD) and lead investigator for POSITRONIC. "We hope this work will contribute to the development of preventative strategies, as well as improved diagnostic and treatment approaches."

Future-Ready Technologies to Study Brain Trauma

Limitations of Traditional TBI Models

Researchers have traditionally employed in vivo models—studies conducted on live animals—and in vitro models, involving cultured cells in laboratory settings, to investigate traumatic brain injuries. Yet, applying these findings to human cases has proved difficult due to the limited relevance of such models to human biology.

Brain Organoids: A Transformative in Vitro Tool

Enter brain organoids—an emerging in vitro model based on human cells. One of their chief advantages lies in their capacity to replicate complex neural networks and cellular dynamics.

Johns Hopkins Team Leads the Charge

Neurotoxicologists Thomas Hartung and Lena Smirnova, of the Bloomberg School, were  instrumental in advancing organoid platforms for trauma research. The POSITRONIC team is leading efforts to apply these brain organoids in studying repeated low-level blast exposures.

Simulating Blasts with Precision

"This highlights the flexibility of organoids as a viable alternative to animal models, offering a platform for exploring yet another complex condition," said Smirnova, Assistant Professor at the Bloomberg School.

Cultivating and Testing Brain Organoids Under Blast Pressure

Once cultivated, the brain organoids is linked to a pressure-generation system that allows researchers to simulate repeated low-level blast exposure, mirroring the pressure commonly encountered by service personnel during training exercises.

Source

Discover how cutting-edge brain organoid research is transforming military traumatic brain injury studies! Dive deeper into health and science breakthroughs today.

  • Learn more about critical health challenges and solutions at Human Health Issues — your source for the latest in global health advancements.
  • Stay updated with teach and science innovations at FSNews365, bringing you the newest research shaping our future.
  • Explore environmental impacts and urgent realities at Earth Day Harsh Reality — raising awareness for a sustainable tomorrow.

Stay informed. Stay empowered. Visit these trusted sites now!

Spaceflight Brain Differences Men vs Women Study

Spaceflight Study Reveals S*x Determined Differences in Astronaut Brain and Vision Responses Edited by FSNews365 New Research Highlights How...